Pre-IPO Review
Pre-IPO ReviewAggregating reviews, news, and community signal on pre-IPO companies

Colossal Biosciences

🧬 BCI/Biotech

De-extinction and species preservation through gene editing — mammoth, thylacine, dodo

De-extinctionCRISPRConservation
$10.2B
Latest valuation
👀 0💬 0
Valuation
$10.2B
Total Funding
$435M+
Founded
2021
HQ
Dallas, TX
📊 View full data on Sacra →

📰 Company News

Colossal Biosciences Advances Woolly Mammoth De-Extinction Project
via Inside the Magic·2026-08-09
Colossal Biosciences Creates Male Dire Wolf Named Romulus
via The Daily News | Texas' Oldest Newspaper·2026-08-08
Colossal Biosciences invests $100 million to resurrect bluebuck antelope
via Daily Maverick·2026-08-06

🤝 Related Companies

📰 Articles

No articles yet. Be the first to share one.

Reviews (0)

🔥 Most Helpful🕐 Newest
No reviews yet. Be the first.